Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:51 AM
Ignite Modification Date:
2025-12-25 @ 4:51 AM
NCT ID:
NCT05639218
Eligibility Criteria:
Inclusion Criteria:
* Very high cardiovascular risk - documented atherosclerotic cardiovascular disease
* On maximally tolerated statin and/or ezetimibe therapy for at least 1 month LDL-C treatment target \<1.4 mmol/l not achieved
* Receiving PCSK9 inhibitor or inclisiran as add-on treatment to maximally tolerated statin dose and/or ezetimibe in the context of optimal pharmacotherapy
* NIRS-IVUS performed (written informed consent for the procedure signed according to regulations in the hospital)
* Available blood test results - plasma lipid profile
* Patient agrees to participate in the study (signed informed consent)
Exclusion Criteria:
* Not fulfilling any of inclusion criteria
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05639218
Study Brief:
Protocol Section:
NCT05639218